Literature DB >> 36134019

Optimal duration of adjuvant temozolomide in glioblastoma: An unsolved and unsolvable problem.

Carmen Balana1.   

Abstract

Entities:  

Year:  2022        PMID: 36134019      PMCID: PMC9476985          DOI: 10.1093/nop/npac054

Source DB:  PubMed          Journal:  Neurooncol Pract        ISSN: 2054-2577


× No keyword cloud information.
  9 in total

1.  Incremental advance or seismic shift? The need to raise the bar of efficacy for drug approval.

Authors:  Alberto Sobrero; Paolo Bruzzi
Journal:  J Clin Oncol       Date:  2009-10-13       Impact factor: 44.544

2.  Limited role for extended maintenance temozolomide for newly diagnosed glioblastoma.

Authors:  Dorothee Gramatzki; Philipp Kickingereder; Bettina Hentschel; Jörg Felsberg; Ulrich Herrlinger; Gabriele Schackert; Jörg-Christian Tonn; Manfred Westphal; Michael Sabel; Uwe Schlegel; Wolfgang Wick; Torsten Pietsch; Guido Reifenberger; Markus Loeffler; Martin Bendszus; Michael Weller
Journal:  Neurology       Date:  2017-03-15       Impact factor: 9.910

3.  Therapy for Diffuse Astrocytic and Oligodendroglial Tumors in Adults: ASCO-SNO Guideline.

Authors:  Nimish A Mohile; Hans Messersmith; Na Tosha Gatson; Andreas F Hottinger; Andrew Lassman; Jordan Morton; Douglas Ney; Phioanh Leia Nghiemphu; Adriana Olar; Jeffery Olson; James Perry; Jana Portnow; David Schiff; Anne Shannon; Helen A Shih; Roy Strowd; Martin van den Bent; Mateo Ziu; Jaishri Blakeley
Journal:  J Clin Oncol       Date:  2021-12-13       Impact factor: 44.544

4.  Dose-dense temozolomide for newly diagnosed glioblastoma: a randomized phase III clinical trial.

Authors:  Mark R Gilbert; Meihua Wang; Kenneth D Aldape; Roger Stupp; Monika E Hegi; Kurt A Jaeckle; Terri S Armstrong; Jeffrey S Wefel; Minhee Won; Deborah T Blumenthal; Anita Mahajan; Christopher J Schultz; Sara Erridge; Brigitta Baumert; Kristen I Hopkins; Tzahala Tzuk-Shina; Paul D Brown; Arnab Chakravarti; Walter J Curran; Minesh P Mehta
Journal:  J Clin Oncol       Date:  2013-10-07       Impact factor: 44.544

5.  A phase II randomized, multicenter, open-label trial of continuing adjuvant temozolomide beyond 6 cycles in patients with glioblastoma (GEINO 14-01).

Authors:  Carmen Balana; Maria Angeles Vaz; Juan Manuel Sepúlveda; Carlos Mesia; Sonia Del Barco; Estela Pineda; Jose Muñoz-Langa; Anna Estival; Ramón de Las Peñas; Jose Fuster; Regina Gironés; Luis Miguel Navarro; Miguel Gil-Gil; Miriam Alonso; Ana Herrero; Sergio Peralta; Clara Olier; Pedro Perez-Segura; Maria Covela; Maria Martinez-García; Alfonso Berrocal; Oscar Gallego; Raquel Luque; Franciso Javier Perez-Martín; Anna Esteve; Nuria Munne; Marta Domenech; Salvador Villa; Carolina Sanz; Cristina Carrato
Journal:  Neuro Oncol       Date:  2020-12-18       Impact factor: 12.300

Review 6.  EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood.

Authors:  Michael Weller; Martin van den Bent; Matthias Preusser; Emilie Le Rhun; Jörg C Tonn; Giuseppe Minniti; Martin Bendszus; Carmen Balana; Olivier Chinot; Linda Dirven; Pim French; Monika E Hegi; Asgeir S Jakola; Michael Platten; Patrick Roth; Roberta Rudà; Susan Short; Marion Smits; Martin J B Taphoorn; Andreas von Deimling; Manfred Westphal; Riccardo Soffietti; Guido Reifenberger; Wolfgang Wick
Journal:  Nat Rev Clin Oncol       Date:  2020-12-08       Impact factor: 66.675

7.  Real-world validity of randomized controlled phase III trials in newly diagnosed glioblastoma: to whom do the results of the trials apply?

Authors:  Erlend Skaga; Marthe Andrea Skretteberg; Tom Børge Johannesen; Petter Brandal; Einar O Vik-Mo; Eirik Helseth; Iver A Langmoen
Journal:  Neurooncol Adv       Date:  2021-02-26

8.  Is more better? The impact of extended adjuvant temozolomide in newly diagnosed glioblastoma: a secondary analysis of EORTC and NRG Oncology/RTOG.

Authors:  Deborah T Blumenthal; Thierry Gorlia; Mark R Gilbert; Michelle M Kim; L Burt Nabors; Warren P Mason; Monika E Hegi; Peixin Zhang; Vassilis Golfinopoulos; James R Perry; Do Hyun Nam; Sara C Erridge; Benjamin W Corn; René O Mirimanoff; Paul D Brown; Brigitta G Baumert; Minesh P Mehta; Martin J van den Bent; David A Reardon; Michael Weller; Roger Stupp
Journal:  Neuro Oncol       Date:  2017-08-01       Impact factor: 12.300

9.  The impact of extended adjuvant temozolomide in newly diagnosed glioblastoma multiforme: a meta-analysis and systematic review.

Authors:  Ehsan Alimohammadi; Seyed Reza Bagheri; Shahram Taheri; Maliheh Dayani; Alireza Abdi
Journal:  Oncol Rev       Date:  2020-02-18
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.